Simple jQuery Dropdowns
Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/32481
Title: Effect of high-dose or split-dose artesunate on parasite clearance in artemisinin-resistant falciparum malaria
Authors: Debashish Das
Rupam Tripura
Aung Pyae Phyo
Khin Maung Lwin
Joel Tarning
Sue J. Lee
Warunee Hanpithakpong
Kasia Stepniewska
Didier Menard
Pascal Ringwald
Kamolrat Silamut
Mallika Imwong
Kesinee Chotivanich
Poravuth Yi
Nicholas P.J. Day
Niklas Lindegardh
Duong Socheat
Chea Nguon
Nicholas J. White
François Nosten
Arjen M. Dondorp
Mahidol University
Shoklo Malaria Research Unit
Nuffield Department of Clinical Medicine
WorldWide Antimalarial Resistance Network
National Center for Parasitology, Entomology and Malaria Control
Institut Pasteur du Cambodge
Organisation Mondiale de la Sante
Keywords: Medicine
Issue Date: 18-Feb-2013
Citation: Clinical Infectious Diseases. Vol.56, No.5 (2013)
Abstract: Background. The emergence of Plasmodium falciparum resistance to artemisinins on the Cambodian and Myanmar-Thai borders poses severe threats to malaria control. We investigated whether increasing or splitting the dose of the short-half-life drug artesunate improves parasite clearance in falciparum malaria in the 2 regions.Methods. In Pailin, western Cambodia (from 2008 to 2010), and Wang Pha, northwestern Thailand (2009-2010), patients with uncomplicated falciparum malaria were randomized to oral artesunate 6 mg/kg/d as a once-daily or twice-daily dose for 7 days, or artesunate 8 mg/kg/d as a once-daily or twice-daily dose for 3 days, followed by mefloquine. Parasite clearance and recrudescence for up to 63 days of follow-up were assessed.Results. A total of 159 patients were enrolled. Overall median (interquartile range [IQR]) parasitemia half-life (half-life) was 6.03 (4.89-7.28) hours in Pailin versus 3.42 (2.20-4.85) hours in Wang Pha (P =. 0001). Splitting or increasing the artesunate dose did not shorten half-life in either site. Pharmacokinetic profiles of artesunate and dihydroartemisinin were similar between sites and did not correlate with half-life. Recrudescent infections occurred in 4 of 79 patients in Pailin and 5 of 80 in Wang Pha and was not different between treatment arms (P =. 68).Conclusions. Increasing the artesunate treatment dose up to 8 mg/kg/d or splitting the dose does not improve parasite clearance in either artemisinin resistant or more sensitive infections with P. falciparum.Clinical Trials Registration. ISRCTN15351875. © 2012 The Author.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84873656674&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/32481
ISSN: 15376591
10584838
Appears in Collections:Scopus 2011-2015

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.